Clinical trial
Application of Proteome Profiler Antibody Arrays to Find Angiogenetic Predictors in Glioma Paitents.
NCT03225963 is registered in ClinicalTrials.gov with Taichung Veterans General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Application of Proteome Profiler Antibody Arrays to Find Angiogenetic Predictors in Glioma Paitents.
- Lead sponsor
- Taichung Veterans General Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- August 1, 2015
- Completion date
- July 31, 2018
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
angiogenesis, glioblastoma multiforme